HomeRAPT • NASDAQ
Rapt Therapeutics Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.54M | -33.40% |
Net income | -17.64M | 36.22% |
Net profit margin | — | — |
Earnings per share | -0.65 | 88.56% |
EBITDA | -19.31M | 33.48% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 168.95M | 47.12% |
Total assets | 178.41M | 40.28% |
Total liabilities | 14.00M | -22.04% |
Total equity | 164.41M | — |
Shares outstanding | 16.54M | — |
Price to book | 1.81 | — |
Return on assets | -26.69% | — |
Return on capital | -28.00% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -17.64M | 36.22% |
Cash from operations | -11.27M | 59.97% |
Cash from investing | -7.26M | -137.79% |
Cash from financing | 161.00K | -77.03% |
Net change in cash | -18.37M | -122.95% |
Free cash flow | -3.00M | 83.27% |
Previous close
$18.00
Day range
$18.14 - $20.90
Year range
$5.67 - $26.56
Market cap
337.71M USD
Avg Volume
116.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
61
